| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 40 |
| 1 | MYCOPHENOLATE MOFETIL | 36 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 36 |
| 3 | METHYLPREDNISOLONE | 25 |
| 4 | ALEMTUZUMAB | 21 |
| 5 | TACROLIMUS | 21 |
| 6 | PREDNISOLONE | 18 |
| 7 | PREDNISOLONE ORAL | 18 |
| 8 | PREDNISOLONE ORAL SOLUTION | 18 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | AMPICILLIN AND SULBACTAM | 4 | 0.0045 |
| 2 | TREOSULFAN | 7 | 0.0025 |
| 3 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 5 | 0.0019 |
| 4 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 5 | VARDENAFIL | 1 | 0.0017 |
| 6 | FLUCYTOSINE | 2 | 0.0014 |
| 7 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 8 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 9 | SODIUM HYALURONATE | 1 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 1 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 21 | 0.0011 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |
| 4 | Antimalarial [EPC] | 2 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 6 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 7 | Integrin Receptor Antagonist [EPC] | 15 | 0.0002 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |